Mechanistically, MYCN promoted miR‐421 upregulation, consequently enhanced ATM expression and its phosphorylation, and then alleviated the senescence of castration‐resistant C4‐2 prostate cancer cell. This evidence concerns the gene ATM and prostate carcinoma.